SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-065991
Filing Date
2019-11-21
Accepted
2019-11-20 21:34:31
Documents
3
Period of Report
2019-11-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1923553d1_8k.htm 8-K 19766
2 EXHIBIT 10.1 tm1923553d1_ex10-1.htm EX-10.1 12449
3 EXHIBIT 10.2 tm1923553d1_ex10-2.htm EX-10.2 109424
  Complete submission text file 0001104659-19-065991.txt   143003
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 191235571
SIC: 3841 Surgical & Medical Instruments & Apparatus